Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia | |
Tong J.; Huang J.; Luo X.; Chen S.; Cui Y.; An H.; Xiu M.; Tan S.; Wang Z.; Yuan Y. | |
刊名 | Brain, Behavior, and Immunity
![]() |
2019 | |
卷号 | Vol.81页码:213-219 |
关键词 | Anti-NMDA receptor antibody Autoimmunity Biomarker Cognitive impairment First-episode patients with schizophrenia |
ISSN号 | 0889-1591 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2904133 |
专题 | 天津大学 |
作者单位 | Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, China Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States Department of Pharmacy, Peking University First Hospital, Beijing, China School of Foreign Languages and Literature, Tianjin University, Tianjin, China Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, United States |
推荐引用方式 GB/T 7714 | Tong J.,Huang J.,Luo X.,et al. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia[J]. Brain, Behavior, and Immunity,2019,Vol.81:213-219. |
APA | Tong J..,Huang J..,Luo X..,Chen S..,Cui Y..,...&Tan Y..(2019).Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.Brain, Behavior, and Immunity,Vol.81,213-219. |
MLA | Tong J.,et al."Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia".Brain, Behavior, and Immunity Vol.81(2019):213-219. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论